ArticleCancers2025

Feasibility and Oncological Safety of Robotic Retroperitoneal Lymph Node Dissection in Patients with Testicular Cancer-Single-Center Experience.

Markus Angerer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.